Pricing
  1. JP-listed companies
  2. Ina Research Inc.
  3. Financials
  4. Total current liabilities

Ina Research Inc. (E20922)

Market cap
P/E ratio
Inari Research provides contract testing services to help pharmaceutical companies evaluate drug safety and effectiveness using GLP-compliant laboratory facilities.
SummaryFinancialsDividendsHistoryWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 20222,678+31.42%
Mar 31, 20212,038+24.30%
Mar 31, 20201,640+13.58%
Mar 31, 20191,444-27.12%
Mar 31, 20181,981+25.25%
Mar 31, 20171,582+37.90%
Mar 31, 20161,147-26.36%
Mar 31, 20151,557-2.07%
Mar 31, 20141,590+1.95%
Mar 31, 20131,560

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat